Genentech Licenses Crohn's Disease GeneMap From Genizon | GenomeWeb
NEW YORK (GenomeWeb News) – Genentech has licensed Genizon Biosciences’ GeneMap of Crohn’s disease to support drug and diagnostics development, Genizon said today.
 
Under the agreement, Genizon will receive an undisclosed upfront payment, research funding, and milestone payments for each therapeutic developed through the collaboration.
 
GeneMap’s disease-associated genes were generated from a whole genome association study of 500 families from the Quebec Founder Population.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.